Oseltamivir News and Research

RSS
TSRI scientists describe severe immune overreaction caused by flu infections

TSRI scientists describe severe immune overreaction caused by flu infections

Scientists identify factors that predict flu severity in patients

Scientists identify factors that predict flu severity in patients

New drug-resistant strain of bird flu appears to retain ability to cause serious disease in humans

New drug-resistant strain of bird flu appears to retain ability to cause serious disease in humans

Pediatrician analyzes management of the 2009 influenza A crisis

Pediatrician analyzes management of the 2009 influenza A crisis

Taiwan scientists confirm world’s first case of wild avian influenza A H6N1 virus in human

Taiwan scientists confirm world’s first case of wild avian influenza A H6N1 virus in human

NanoViricides, LRRI sign NDA for IND-enabling efficacy studies on FluCide drug candidates

NanoViricides, LRRI sign NDA for IND-enabling efficacy studies on FluCide drug candidates

Some strains of avian H7N9 influenza develop resistance to antiviral drugs

Some strains of avian H7N9 influenza develop resistance to antiviral drugs

Romark Laboratories starts NT-300 Phase 3 trial for treatment of acute uncomplicated influenza

Romark Laboratories starts NT-300 Phase 3 trial for treatment of acute uncomplicated influenza

New assays are effective in managing patients with influenza virus infection

New assays are effective in managing patients with influenza virus infection

Study: Half of Tamiflu prescriptions during 2009-10 influenza pandemic went unused in England

Study: Half of Tamiflu prescriptions during 2009-10 influenza pandemic went unused in England

Genetic analysis of H7N9 portrays that virus evolves to adapt to human cells

Genetic analysis of H7N9 portrays that virus evolves to adapt to human cells

Three NIH-sponsored influenza trials begin to enroll volunteers

Three NIH-sponsored influenza trials begin to enroll volunteers

NanoViricides’ oral FluCide dramatically improves survival in animals with H3N2 influenza A

NanoViricides’ oral FluCide dramatically improves survival in animals with H3N2 influenza A

Strong antiviral antibody response observed in oral administration of Flucide

Strong antiviral antibody response observed in oral administration of Flucide

Oral FluCide drug candidates effective in reducing lung viral load: NanoViricides

Oral FluCide drug candidates effective in reducing lung viral load: NanoViricides

WSU researcher looks for clues on link between H1N1 flu and obesity

WSU researcher looks for clues on link between H1N1 flu and obesity

One of the controversial avian flu studies published in full finally

One of the controversial avian flu studies published in full finally

NanoViricides files FluCide pre-IND briefing document with the FDA

NanoViricides files FluCide pre-IND briefing document with the FDA

C&EN explains logic behind odd-sounding generic names

C&EN explains logic behind odd-sounding generic names